BRIEF published on 08/19/2025 at 15:25, 8 months 21 days ago Swissnet AG : forte croissance et perspectives positives Résultats De L'exercice 2024 Recommandation De L'analyste Swissnet SA Plateforme TIC Et SaaS Contrat Wi-Fi
BRIEF published on 08/19/2025 at 15:10, 8 months 21 days ago Eurobattery Minerals Publishes Q2 2025 Report, Launches San Juan Tungsten Project Eurobattery Minerals Tungsten Mining San Juan Project Q2 2025 Report Raw Materials Strategy
BRIEF published on 08/19/2025 at 15:10, 8 months 21 days ago Eurobattery Minerals publie son rapport du deuxième trimestre 2025 et lance le projet de tungstène de San Juan Eurobattery Minerals Extraction De Tungstène Projet San Juan Rapport Du Deuxième Trimestre 2025 Stratégie Des Matières Premières
BRIEF published on 08/19/2025 at 15:08, 8 months 21 days ago Finexity AG Acquires Majority Stake in Effecta GmbH Acquisition Investment Digital Assets FINEXITY AG Effecta GmbH
BRIEF published on 08/19/2025 at 15:08, 8 months 21 days ago Finexity AG acquiert une participation majoritaire dans Effecta GmbH Acquisition Investissement Actifs Numériques FINEXITY AG Effecta GmbH
BRIEF published on 08/19/2025 at 15:05, 8 months 21 days ago Partners Group Announces Interim Financial Results Presentation Switzerland Partners Group SIX Swiss Exchange Earnings Presentation 2025 Financial Results
BRIEF published on 08/19/2025 at 15:05, 8 months 21 days ago Partners Group annonce la présentation de ses résultats financiers intermédiaires Suisse SIX Swiss Exchange Présentation Des Résultats Groupe De Partenaires Résultats Financiers 2025
BRIEF published on 08/19/2025 at 15:05, 8 months 21 days ago Jaguar Health's Napo Pharmaceuticals Seeks FDA Guidance on Crofelemer for Rare Pediatric Disease Napo Pharmaceuticals Jaguar Health Crofelemer Trials FDA Meeting MVID Treatment
BRIEF published on 08/19/2025 at 15:05, 8 months 21 days ago Napo Pharmaceuticals, filiale de Jaguar Health, sollicite l'avis de la FDA sur le crofelemer pour le traitement d'une maladie pédiatrique rare. Napo Pharmaceuticals Jaguar Health Réunion De La FDA Traitement MVID Essais Crofelemer
BRIEF published on 08/19/2025 at 14:35, 8 months 21 days ago Sekur Partners with Rich TV to Expand Privacy Solutions Reach Cybersecurity Solutions Crypto Payment Privacy Partnership Rich TV Distribution Swiss Data Protection
Published on 05/09/2026 at 01:30, 23 hours 26 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/09/2026 at 19:05, 5 hours 51 minutes ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 4 hours ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 day 5 hours ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 day 5 hours ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 2 days 5 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 2 days 5 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 days 5 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 days 5 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 days 5 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
